GME Meeting Planner
Join fellow healthcare professionals for this symposium featuring the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.
This activity is supported by independent educational grants from Allergan, Ironshore, Lundbeck, Merck, Otsuka, Shire, and Sunovion Pharmaceuticals.
Discounted Room Block at JW Marriott Essex House
GME is pleased to offer a discounted room rate for attendees at this meeting. To make your reservations, please follow the link below or call the hotel directly and mention Global Medical Education. We do expect rooms to sell out quickly, so please book your rooms early!
Website Address: https://resweb.passkey.com/go/globalmed
Pharmacotherapy is the mainstay of treatment for psychiatric illnesses. The symposium will address our understanding of the neurobiology of psychiatric illnesses and hypothesis of how these medications work including their effects on synaptic function, gene expression and neurotrophic factors. The symposium will also address the role of non-pharmacological treatments that busy psychopharmacologists can incorporate into their practice that will enhance remission and improve outcomes. The important role of the therapeutic alliance will be emphasized throughout this symposium.
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, registered nurses, psychologists, and pharmacists who care for patients with psychiatric illnesses.
After completing this activity, the participant should be better able to:
-Employ the appropriate treatment of substance dependence
-Evaluate the role of innovative treatments in treatment resistant depression
-Implement evidence based pharmacotherapy for mood disorders
-Execute evidence based pharmacotherapy for schizophrenia
-Carry out evidence based pharmacotherapy for ADHD
-Implement evidence based pharmacotherapy for anxiety disorders
-Realize evidence based pharmacotherapy for sleep disorders
-Execute evidence based pharmacotherapy for binge eating disorder
-Assess latest advances in treatment of antipsychotic induced movement disorders
-Implement evidence based pharmacotherapy for premenstrual, postpartum and perimenopausal depression
-Provide appropriate care and counsel for patients and their families
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Global Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Psychology Education
Postgraduate Institute for Medicine (PIM) is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content.
This program offers 15.0 continuing education credits for psychologists.
Continuing Pharmacy Education
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Postgraduate Institute for Medicine designates this continuing education activity for 15.0 contact hour(s) (1.50 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Numbers:
Friday AM: 0809-9999-17-703-L01-P; Application, 4.0 hours
Friday PM: 0809-9999-17-704-L01-P; Knowledge, 4.0 hours
Saturday AM: 0809-9999-17-705-L01-P; Application, 4.0 hours
Saturday PM: 0809-9999-17-706-L01-P; Application, 3.0 hours
Continuing Nursing Education
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 15.0 contact hours is provided by Postgraduate Institute for Medicine. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Angela Masand prior to the live event at [email protected]
There is no fee for this educational activity.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within three weeks.
For Pharmacists: Upon receipt of the completed activity evaluation form, you will receive an email from [email protected] within 4 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.
Day 1 - Friday, September 8
7:30 - 8:15 AM: Registration and Breakfast
8:15 - 8:30 AM: Opening Remarks
8:30 - 9:30 AM: Keynote Address: "How Do Antidepressants Work: From Receptors to Clinical Response" - Alan Schatzberg, MD (Stanford University)
9:30 - 10:30 AM: “Pharmacotherapies for Psychiatric Disorders: What Does the Future Hold?" - Roger McIntyre, MD (Univesrity of Toronto)
10:30 - 11:30 AM: “Pharmacotherapy of Schizophrenia” - Oliver Freudenreich, MD (Harvard)
11:30 - 11:45 AM: Coffee Break
11:45 AM - 12:45 PM: Hot Topics (Six clinically relevant and topical issues for 8 minutes each)
12:45-2:00 PM: Lunch
2:00 – 3:00 PM: “Pharmacotherapy of Premenstrual, Menopausal and Postpartum Depression” - Samantha Meltzer-Brody, MD (UNC Chapel Hill)
3:00 – 4:00 PM: "Pharmacotherapy of Binge Eating Disorder" - Susan McElroy MD (University of Cincinnati)
4:00 – 5:00 PM: “Pharmacotherapy of Insomnia and Narcolepsy” - Michael Thorpy, MD (Montefiore Medical Center)
5.00 – 6.00 PM: "Pharmacotherapy of Antipsychotic Induced Movement Disorders" - Prakash Masand, MD (Duke-NUS)
Day 2 - Saturday, September 9
7:30 – 8:30 AM: Breakfast
8:30 – 9:30 AM: “Pharmacotherapy of Bipolar Spectrum Disorders" - Joseph Goldberg, MD (Mt. Sinai)
9:30 – 10:30 AM: “Pharmacotherapy of Treatment Resistant Mood Disorders” - Dan Iosifescu, MD (NYU)
10:30 – 11:30 AM: "Role of Long-Acting Injectables in Psychiatric Illness" - Joseph McEvoy, MD (Georgia Regents University)
11:30 -11:45 AM: Coffee Break
11:45 AM – 12:45 PM: Hot Topics (Six clinically relevant and topical issues for 8 minutes each)
12:45 – 2:00 PM: Lunch
2:00 – 3:00 PM: "Pharmacotherapy of Substance Abuse Disorders in Psychiatric Patients" - Ashwin Patkar, MD (Duke)
3:00 – 4:00 PM: “Pharmacotherapy of ADHD Across the Life Span” - Anthony Rostain, MD (University of Pennsylvania)
4:00 – 5:00 PM: "Pharmacotherapy of Anxiety Disorders" - Greg Mattingly, MD (Washington University)
*Note, tentative agenda, subject to change.